{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:14:05Z","timestamp":1790291645384,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejim.2024.02.015","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T21:25:48Z","timestamp":1709933148000},"page":"22-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-2289","authenticated-orcid":false,"given":"Emma Diletta","family":"Stea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"D'Ettorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7037-7773","authenticated-orcid":false,"given":"Adele","family":"Mitrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4861-0911","authenticated-orcid":false,"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ejim.2024.02.015_bib0001","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.02.015_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.imlet.2014.10.010","article-title":"The innate immune response","volume":"162","author":"Koenderman","year":"2014","journal-title":"Immunol Lett"},{"issue":"20","key":"10.1016\/j.ejim.2024.02.015_bib0003","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.3390\/jcm10204715","article-title":"The Contribution of Complement to the Pathogenesis of IgA Nephropathy:Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?","volume":"10","author":"Poppelaars","year":"2021","journal-title":"J Clin Med"},{"issue":"20","key":"10.1016\/j.ejim.2024.02.015_bib0004","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.3390\/jcm10204715","article-title":"The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?","volume":"10","author":"Poppelaars","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2024.02.015_bib0005","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.4049\/jimmunol.162.7.4336","article-title":"Contribution of renal secreted complement C3 to the circulating pool in humans","volume":"162","author":"Tang","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5527\/wjn.v4.i1.31","article-title":"Complement activation in progressive renal disease","volume":"4","author":"Fearn","year":"2015","journal-title":"World J Nephrol"},{"issue":"3","key":"10.1016\/j.ejim.2024.02.015_bib0007","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0008","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: State of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1008294","article-title":"Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation","volume":"13","author":"Stea","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860689","article-title":"Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside","author":"Meuleman","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0011","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3389\/fimmu.2019.01030","article-title":"C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ejim.2024.02.015_bib0012","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ndt\/gfab281","article-title":"Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment","volume":"38","author":"Noris","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0013","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0014","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1681\/ASN.2017030258","article-title":"Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies\/Immune Complex-Mediated Membranoproliferative GN","volume":"29","author":"Iatropoulos","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"January (1)","key":"10.1016\/j.ejim.2024.02.015_bib0015","first-page":"21","article-title":"Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature","volume":"87","author":"Nasr","year":"2008","journal-title":"Bull. Sch. Med. Md"},{"issue":"3","key":"10.1016\/j.ejim.2024.02.015_bib0016","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ckj\/sfw032","article-title":"Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy M.A. Khalighi","volume":"9","year":"2016","journal-title":"ChangClin. Kidney J."},{"key":"10.1016\/j.ejim.2024.02.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101331","article-title":"Complement dysregulation in glomerulonephritis","volume":"45","author":"Kaartinen","year":"2019","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.ejim.2024.02.015_bib0018","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.ejim.2024.02.015_bib0019","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00467-015-3311-3","article-title":"C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum","volume":"31","author":"Al-Ghaithi","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0020","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.3390\/ijms24098432","article-title":"Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 Glomerulopathy","volume":"24","author":"Wada","year":"2023","journal-title":"Int. J. Mol.Sci."},{"key":"10.1016\/j.ejim.2024.02.015_bib0021","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.ejim.2024.02.015_bib0022","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2215\/CJN.04300321","article-title":"Collectin11 and Complement Activation in IgA Nephropathy","volume":"16","author":"Wei","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0023","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12014-017-9165-x","article-title":"Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy","volume":"14","author":"Paunas","year":"2017","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.ejim.2024.02.015_bib0024","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/ndt\/13.8.1984","article-title":"Glomerular deposition of mannose-binding lectin (MBL)indicates a novel mechanism of complement activation in IgA nephropathy","volume":"13","author":"Endo","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.ejim.2024.02.015_bib0025","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0026","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2215\/CJN.02530317","article-title":"Mesangial C4d deposits in early IgA nephropathy","volume":"3","author":"Segarra","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ejim.2024.02.015_bib0027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2215\/CJN.19491220","article-title":"Assessing Genetic Risk for IgA Nephropathy: State of the Art","volume":"16","author":"Prakash","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0028","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-med-041811-142014","article-title":"Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies","volume":"64","author":"Kiryluk","year":"2013","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0029","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.kint.2017.03.043","article-title":"Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy","volume":"92","author":"Medjeral-Thomas","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.kint.2017.03.041","article-title":"Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy","volume":"92","author":"Tortajada","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.02.015_bib0031","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/eji.1830170304","article-title":"Activation of the alternative pathway of complement by human serum IgA","volume":"17","author":"Hiemstra","year":"1987","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0032","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2249.1993.tb03430.x","article-title":"An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies","volume":"92","author":"Stad","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0033","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complementsystem via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0034","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fimmu.2019.00537","article-title":"A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy","volume":"10","author":"Ouyang","year":"2019","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ejim.2024.02.015_bib0035","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1681\/ASN.2017010076","article-title":"Mannose-Binding Lectin Levels Could Predict Prognosis in IgA Nephropathy","volume":"28","author":"Guo","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ejim.2024.02.015_bib0036","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ekir.2017.11.015","article-title":"Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin-Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H-Related Protein-5 (FHR5) Deposition","volume":"3","author":"Medjeral-Thomas","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0037","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/cei.12961","article-title":"Targeting C3a\/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice","volume":"189","author":"Zhang","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0038","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00281-014-0423-y","article-title":"Immunopathogenesis of membranous nephropathy: an update","volume":"36","author":"Debiec","year":"2014","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0039","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med"},{"issue":"December (24)","key":"10.1016\/j.ejim.2024.02.015_bib0040","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejim.2024.02.015_bib0041","first-page":"1993","article-title":"Advances of the experimental models of idiopathic membranous nephropathy (Review)","volume":"21","author":"Jiang","year":"2020","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0042","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.179.1.172","article-title":"Induction of passive Heymann nephritis in complement component 6-deficient PVG rats","volume":"179","author":"Spicer","year":"2007","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ejim.2024.02.015_bib0043","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.semnephrol.2013.08.009","article-title":"Complement-mediated cellular injury","volume":"33","author":"Takano","year":"2013","journal-title":"Semin Nephrol"},{"issue":"2","key":"10.1016\/j.ejim.2024.02.015_bib0044","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4049\/jimmunol.143.2.546","article-title":"Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy","volume":"143","author":"Kerjaschki","year":"1989","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ejim.2024.02.015_bib0045","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ki.1995.496","article-title":"Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy","volume":"48","author":"Kon","year":"1995","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0046","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12882-019-1509-5","article-title":"Complement activation products in the circulation and urine of primary membranous nephropathy","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1016\/j.ejim.2024.02.015_bib0047","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1681\/ASN.2021101384","article-title":"Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy","volume":"33","author":"Gao","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0048","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5935\/0101-2800.20170068","article-title":"Complement System and C4d expression in cases of Membranous nephropathy","volume":"39","author":"Cust\u00f3dio","year":"2017","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0049","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.ekir.2019.07.015","article-title":"Epidemiology and pathophysiology of glomerular C4d staining in native kidney biopsies","volume":"4","author":"Drachenberg","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ejim.2024.02.015_bib0050","first-page":"76","article-title":"C4d immunohistochemistry in membranous nephropathy","volume":"6","author":"Hui","year":"2014","journal-title":"J. Lab. Phys."},{"key":"10.1016\/j.ejim.2024.02.015_bib0051","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000185234","article-title":"Glomerular deposition of C4 cleavage fragment (C4d) and C4-Binding protein in idiopathic membranous glomerulonephritis","volume":"51","author":"Kusunoki","year":"1989","journal-title":"Nephron"},{"key":"10.1016\/j.ejim.2024.02.015_bib0052","first-page":"1391","article-title":"C4d immunohistochemical staining is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in membranous glomerulonephritis","volume":"26","author":"Val-Bernal","year":"2011","journal-title":"Histol Histopathol"},{"issue":"5","key":"10.1016\/j.ejim.2024.02.015_bib0053","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jfma.2018.12.026","article-title":"The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy","volume":"118","author":"Chi","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ejim.2024.02.015_bib0054","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41379-019-0267-z","article-title":"Diagnostic role of renal biopsy in PLA2R1- antibody-positive patients with nephrotic syndrome","volume":"32","author":"Wiech","year":"2019","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.ejim.2024.02.015_bib0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.ejim.2024.02.015_bib0056","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0057","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-2776(08)04004-2","article-title":"The amplification loop of the complement pathways","volume":"104","author":"Lachmann","year":"2009","journal-title":"Adv Immunol"},{"issue":"6","key":"10.1016\/j.ejim.2024.02.015_bib0058","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00467-009-1439-8","article-title":"IgG subclasses and complement pathway in segmental and global membranous nephropathy","volume":"25","author":"Segawa","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0059","doi-asserted-by":"crossref","first-page":"c147","DOI":"10.1159\/000079174","article-title":"Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy","volume":"97","author":"Endo","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ejim.2024.02.015_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0076-6879(88)62096-9","article-title":"Experimental glomerulonephritis","volume":"162","author":"Salant","year":"1988","journal-title":"Methods Enzymol"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0061","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12349","article-title":"Human IgG4: a structural perspective","volume":"268","author":"Davies","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ejim.2024.02.015_bib0062","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-065X.2001.1800101.x","article-title":"The role of complement in inflammation and adaptive immunity","volume":"180","author":"Barrington","year":"2001","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.ejim.2024.02.015_bib0063","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180131","article-title":"Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway","volume":"38","author":"Wang","year":"2018","journal-title":"Biosci Rep"},{"issue":"5","key":"10.1016\/j.ejim.2024.02.015_bib0064","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2013020166","article-title":"Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy?","volume":"24","author":"Salant","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0066","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12026-016-8790-1","article-title":"IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study","volume":"64","author":"Yang","year":"2016","journal-title":"Immunol Res"},{"issue":"12","key":"10.1016\/j.ejim.2024.02.015_bib0067","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1681\/ASN.2015101155","article-title":"Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency","volume":"27","author":"Bally","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0068","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3389\/fimmu.2018.01433","article-title":"Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy","volume":"9","author":"Luo","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0069","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.ASN.0000103229.25389.40","article-title":"Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis","volume":"15","author":"Levidiotis","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0070","doi-asserted-by":"crossref","first-page":"E534","DOI":"10.1073\/pnas.1612385114","article-title":"Properdin binding to complement activating surfaces depends on initial C3b deposition","volume":"114","author":"Harboe","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ejim.2024.02.015_bib0071","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1084\/jem.188.7.1353","article-title":"Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis","volume":"188","author":"Schiller","year":"1998","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.ejim.2024.02.015_bib0072","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1681\/ASN.V5111888","article-title":"The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis","volume":"5","author":"Couser","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0073","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3389\/fimmu.2019.02166","article-title":"Complement Inhibitors in Clinical Trials for Glomerular Diseases","volume":"10","author":"Zipfel","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0074","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-020117-043811","article-title":"Molecular Pathogenesis of Membranous Nephropathy","volume":"15","author":"Ronco","year":"2020","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.ejim.2024.02.015_bib0075","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1681\/ASN.2005010096","article-title":"Contrasting roles of complement activation and its regulation in membranous nephropathy","volume":"16","author":"Cunningham","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0076","first-page":"668A","article-title":"Eculizumab (C5a complement inhibitor) in the treatment of idiopathic membranous nephropathy [abstract]","volume":"13","author":"Appel","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0077","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1021\/acs.jmedchem.9b01870","article-title":"Discovery of 4-((2 S, 4 S)- 4-Ethoxy-1-((5-methoxy-7-methyl-1 H -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B inhibitor specifically designed to be applicable to treating a diverse array of complement mediated diseases","volume":"63","author":"Mainolfi","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.ejim.2024.02.015_bib0078","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1073\/pnas.1820892116","article-title":"Small-molecule factor B inhibitor for the treatment of complement-mediated diseases","volume":"116","author":"Schubart","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0079","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3349\/ymj.2022.0435","article-title":"Comparison of the 2022 ACR\/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Previous Criteria","volume":"64","author":"Pyo","year":"2023","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/BOR.0000000000000914","article-title":"The complement system in antineutrophil cytoplasmic antibody-associated vasculitis: pathogenic player and therapeutic target","volume":"35","author":"Mazzariol","year":"2023","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.ejim.2024.02.015_bib0081","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/art.41011","article-title":"Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"71","author":"Wu","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.ejim.2024.02.015_bib0082","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ki.2013.134","article-title":"Novel roles of complement in renal diseases and their therapeutic consequences","volume":"84","author":"Wada","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.ejim.2024.02.015_bib0083","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2215\/CJN.02790313","article-title":"Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN","volume":"8","author":"Gou","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0084","unstructured":"Merkel P.A., Jayne D.R., Wang C., Hillson J., Bekker P. Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide\/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial."},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MAJ.0b013e31827f4ee3","article-title":"Lupus nephritis and end-stage kidney disease","volume":"346","author":"Maroz","year":"2013","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.ejim.2024.02.015_bib0086","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/jcm10040626","article-title":"Expanding the Role of Complement Therapies: The Case for Lupus Nephritis","volume":"10","author":"Li","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ejim.2024.02.015_bib0087","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/biom13020367","article-title":"Complement as a Biomarker for Systemic Lupus Erythematosus","volume":"13","author":"Ayano","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0088","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ng0598-3","article-title":"The lupus paradox","volume":"19","author":"Carroll","year":"1998","journal-title":"Nat Genet"},{"issue":"10225","key":"10.1016\/j.ejim.2024.02.015_bib0089","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2024.02.015_bib0090","article-title":"Cellular senescence of renal tubular epithelial cells in renal fibrosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0091","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5527\/wjn.v4.i1.31","article-title":"Complement activation in progressive renal disease","volume":"4","author":"Fearn","year":"2015","journal-title":"World J Nephrol"},{"issue":"9","key":"10.1016\/j.ejim.2024.02.015_bib0092","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2011111072","article-title":"C3a and C5a promote renal ischemia-reperfusion injury","volume":"23","author":"Peng","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ejim.2024.02.015_bib0093","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/ajt.13415","article-title":"Complement Modulation of Anti-Aging Factor Klotho in Ischemia\/Reperfusion Injury and Delayed Graft Function","volume":"16","author":"Castellano","year":"2016","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ejim.2024.02.015_bib0094","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/ajt.16350","article-title":"DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via complement-mediated cellular senescence","volume":"21","author":"Pesce","year":"2021","journal-title":"Am J Transplant"},{"issue":"13","key":"10.1016\/j.ejim.2024.02.015_bib0095","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.18632\/aging.102059","article-title":"Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4\/\u03b2catenin signaling after ischemia\/reperfusion injury","volume":"11","author":"Castellano","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejim.2024.02.015_bib0096","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3389\/fimmu.2020.00734","article-title":"Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage","volume":"11","author":"Franzin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0097","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41581-018-0071-x","article-title":"The multifaceted role of complement in kidney transplantation","volume":"14","author":"Biglarnia","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0098","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10157-017-1405-x","article-title":"Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology","volume":"22","author":"Mizuno","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0099","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.imbio.2014.10.026","article-title":"Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters","volume":"220","author":"Reis","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejim.2024.02.015_bib0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrneph.2017.17","article-title":"Cardiovascular disease in haemodialysis: role of the intravascular innate immune system","volume":"13","author":"Ekdahl","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0101","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000093613","article-title":"The impact of the pre-transplant renal replacement modality on outcome after cadaveric kidney transplantation: the ghent experience","volume":"150","author":"van Biesen","year":"2006","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0102","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fmed.2017.00066","article-title":"Complement in kidney transplantation","volume":"4","author":"Cernoch","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.ejim.2024.02.015_bib0103","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/TP.0000000000000500","article-title":"Hypoxia and complement-and-coagulation pathways in the deceased organ donor as the major target for intervention to improve renal allograft outcome","volume":"99","author":"Damman","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.02.015_bib0104","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2215\/CJN.02200312","article-title":"Clinical analysis of perioperative complement activity during ischemia\/reperfusion injury following renal transplantation","volume":"7","author":"B\u0142ogowski","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/TP.0b013e318222c9a0","article-title":"Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient","volume":"92","author":"Damman","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.02.015_bib0106","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/SHK.0b013e3182471795","article-title":"Early complementopathy after multiple injuries in humans","volume":"37","author":"Burk","year":"2012","journal-title":"Shock"},{"key":"10.1016\/j.ejim.2024.02.015_bib0107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcrc.2017.11.025","article-title":"Hemorrhagic shock drives glycocalyx, barrier and organ dysfunction early after polytrauma","volume":"44","author":"Halbgebauer","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.ejim.2024.02.015_bib0108","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1600-6143.2011.03880.x","article-title":"Association of complement C3 gene variants with renal transplant outcome of deceased cardiac dead donor kidneys","volume":"12","author":"Damman","year":"2012","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"10.1016\/j.ejim.2024.02.015_bib0109","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1681\/ASN.2008111145","article-title":"Expression of complement components differs between kidney allografts from living and deceased donors","volume":"20","author":"Naesens","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00007890-200002150-00017","article-title":"Activation of inflammatory mediators in rat renal isografts by donor brain death","volume":"69","author":"Kusaka","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.02.015_bib0111","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1093\/ndt\/gfq717","article-title":"Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation","volume":"26","author":"Damman","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2024.02.015_bib0112","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2011111072","article-title":"C3a and C5a promote renal ischemia-reperfusion injury","volume":"23","author":"Peng","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0113","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/ajt.12130","article-title":"Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction","volume":"13","author":"Van Werkhoven","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2024.02.015_bib0114","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/bj2100567","article-title":"Enzymic assay of C3b receptor on intact cells and solubilized cells","volume":"210","author":"Sim","year":"1983","journal-title":"Biochem J"},{"key":"10.1016\/j.ejim.2024.02.015_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/694312","article-title":"Modulation of Endothelial Glycocalyx Structure under Inflammatory Conditions","volume":"2014","author":"Kol\u00e1\u0159ov\u00e1","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ejim.2024.02.015_bib0116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0975-3583.64432","article-title":"Novel mechanisms of endothelial dysfunction in diabetes","volume":"1","author":"Yang","year":"2010","journal-title":"J Cardiovasc Dis Res"},{"key":"10.1016\/j.ejim.2024.02.015_bib0117","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2215\/CJN.06230614","article-title":"Molecules Great and Small: The Complement System","volume":"10","author":"Mathern","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0118","first-page":"217","article-title":"Local extravascular pool of C3 is a determinant of postischemic acute renal failure","volume":"20","author":"Farrar","year":"2006","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ejim.2024.02.015_bib0119","doi-asserted-by":"crossref","first-page":"F821","DOI":"10.1152\/ajprenal.00224.2015","article-title":"Molecular mechanisms of ischemic preconditioning in the kidney","volume":"309","author":"Kapitsinou","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejim.2024.02.015_bib0120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/ndt\/gft516","article-title":"Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia\/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway","volume":"29","author":"Curci","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2024.02.015_bib0121","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2353\/ajpath.2010.090276","article-title":"Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage","volume":"176","author":"Castellano","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0122","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/ajt.13415","article-title":"Complement modulation of anti-aging factor klotho in ischemia\/reperfusion injury and delayed graft function","volume":"16","author":"Castellano","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ejim.2024.02.015_bib0123","first-page":"263","article-title":"Complement-dependent NADPH oxidase enzyme activation in renal ischemia\/reperfusion injury. Free Radic","volume":"74","author":"Simone","year":"2014","journal-title":"Biol Med"},{"key":"10.1016\/j.ejim.2024.02.015_bib0124","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1681\/ASN.2005070698","article-title":"Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia\/reperfusion injury","volume":"17","author":"Thurman","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0125","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.18632\/aging.102059","article-title":"Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4\/betacatenin signaling after ischemia\/reperfusion injury","volume":"11","author":"Castellano","year":"2019","journal-title":"Aging (Albany. NY)."},{"key":"10.1016\/j.ejim.2024.02.015_bib0126","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00734","article-title":"Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage","author":"Franzin","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2024.02.015_bib0127","first-page":"7","article-title":"Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease","author":"Jalal","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejim.2024.02.015_bib0128","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s10157-013-0781-0","article-title":"Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease","volume":"17","author":"He","year":"2013","journal-title":"Clin Exp Nephrol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T01:22:42Z","timestamp":1731547362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":128,"alternative-id":["S0953620524000694"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.02.015","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}